Latest drug developments in the field of cardiovascular disease

Autor:	Craig Stern, Jason Lebowitz
Rok vydání:	2010
Předmět:	Drug Pathology medicine.medical_specialty business.industry media_common.quotation_subject Alternative medicine MEDLINE Context (language use) Review Disease Cardiovascular agent medicine New entrants Drug pipeline Cardiology and Cardiovascular Medicine Intensive care medicine business media_common
Zdroj:	International Journal of Angiology. 19:e100-e105
ISSN:	1615-5939 1061-1711
DOI:	10.1055/s-0031-1278379
Popis:	Cardiovascular disease has been responsible for more deaths annually than any other disease category since 1900, except for the influenza epidemic in 1916. Yet, the drug pipeline has been largely bereft of new entrants. In 2008, one new cardiovascular medication was marketed in the United States. In 2009, there were two new cardiovascular medications. In comparison, there were seven new drugs for oncology in 2009. The present review explores new agents within the context of models currently in the drug pipeline. Of course, there is no guarantee that any of these agents will be marketed. A discussion of the models is illustrative of the types of approaches being used to develop new cardiovascular agents.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d09fcca8c9e46a34211717ceeb74297c https://doi.org/10.1055/s-0031-1278379 Zobrazit plný text záznamu